Augusta Health Introduces Abbott Volt Pulsed Field Ablation for AFib Treatment

Augusta Health has introduced the Abbott Volt Pulsed Field Ablation System to provide a safer alternative for patients treating atrial fibrillation (AFib), according to reporting from the News Leader. The system uses a non-thermal energy source to treat heart rhythm disorders, aiming to reduce the risks associated with traditional ablation methods.

Abbott Volt System and AFib Treatment

The Abbott Volt system utilizes pulsed field ablation (PFA) to target the heart tissue causing irregular rhythms. According to the News Leader, this technology is positioned as a safer option for patients because it avoids the use of extreme heat or cold, which are the primary mechanisms in traditional radiofrequency or cryoablation procedures.

Atrial fibrillation is a condition where the upper chambers of the heart beat out of sync with the lower chambers. This irregularity can lead to blood clots, stroke, and heart failure if left untreated. The Volt system is designed to isolate the areas of the heart causing these irregular electrical signals.

Clinical Application at Augusta Health

By integrating the Abbott Volt system, Augusta Health expands its cardiovascular capabilities for residents in Augusta County, Staunton, Waynesboro, and Fishersville. The adoption of PFA technology is intended to minimize the risk of collateral damage to surrounding organs, such as the esophagus or phrenic nerve, which can occur during thermal ablation.

The non-thermal nature of the pulsed field energy allows the system to create precise lesions in the heart tissue. This precision is intended to improve the efficacy of the procedure while shortening the overall time the patient spends in the operating room.